Hält derzeit eine Position bei Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Co-Founder, Director | Apellis Pharmaceuticals Inc | 1. Januar 2016 - |
President, Chief Executive Officer, Director | Apellis Pharmaceuticals Inc | 1. September 2009 - 1. Januar 2016 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-02-13 | 2024-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
3.962
-1.2%
67,77268.492 USD |
3.962 -1.2% | 67,77 | 268.492 USD | |
2024-01-31 | 2024-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
2.843
-0.9%
64,14182.345 USD |
2.843 -0.9% | 64,14 | 182.345 USD | |
2024-01-23 | 2024-01-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
13.431
-4.0%
65,00872.961 USD |
13.431 -4.0% | 65,00 | 872.961 USD | |
2024-01-17 | 2024-01-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
7.851
-2.3%
66,81524.514 USD |
7.851 -2.3% | 66,81 | 524.514 USD | |
2023-11-21 | 2023-11-21 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
5.000
-1.8%
48,80244.000 USD |
5.000 -1.8% | 48,80 | 244.000 USD | |
2023-09-01 | 2023-09-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
10.284
-2.4%
42,44436.453 USD |
10.284 -2.4% | 42,44 | 436.453 USD | |
2023-09-01 | 2023-09-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
139.716
-24.3%
41,705.826.506 USD |
139.716 -24.3% | 41,70 | 5.826.506 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
2.120
-0.8%
87,67185.869 USD |
2.120 -0.8% | 87,67 | 185.869 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
7.528
-2.6%
87,02655.059 USD |
7.528 -2.6% | 87,02 | 655.059 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
3.007
-1.0%
85,90258.305 USD |
3.007 -1.0% | 85,90 | 258.305 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
14.611
-4.8%
85,011.242.065 USD |
14.611 -4.8% | 85,01 | 1.242.065 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
1.800
-0.6%
83,85150.921 USD |
1.800 -0.6% | 83,85 | 150.921 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
934
-0.3%
83,1777.682 USD |
934 -0.3% | 83,17 | 77.682 USD | |
2023-04-20 | 2023-04-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
30.000
-4.5%
82,022.460.720 USD |
30.000 -4.5% | 82,02 | 2.460.720 USD | |
2022-12-21 | 2022-12-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
24.449
-2.5%
52,071.273.052 USD |
24.449 -2.5% | 52,07 | 1.273.052 USD | |
2020-12-16 | 2020-12-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-0.4%
52,16260.800 USD |
5.000 -0.4% | 52,16 | 260.800 USD | |
2020-11-17 | 2020-11-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-0.5%
39,38196.900 USD |
5.000 -0.5% | 39,38 | 196.900 USD | |
2020-10-16 | 2020-10-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-0.5%
34,46172.300 USD |
5.000 -0.5% | 34,46 | 172.300 USD | |
2020-09-16 | 2020-09-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-0.5%
30,96154.800 USD |
5.000 -0.5% | 30,96 | 154.800 USD | |
2020-08-21 | 2020-08-20 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
3.457
-0.3%
30,00103.710 USD |
3.457 -0.3% | 30,00 | 103.710 USD | |
2020-08-20 | 2020-08-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
1.543
-0.1%
30,0046.290 USD |
1.543 -0.1% | 30,00 | 46.290 USD | |
2020-07-16 | 2020-07-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-0.5%
32,12160.600 USD |
5.000 -0.5% | 32,12 | 160.600 USD | |
2020-06-16 | 2020-06-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-0.5%
30,21151.050 USD |
5.000 -0.5% | 30,21 | 151.050 USD | |
2020-05-19 | 2020-05-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-0.4%
29,92149.600 USD |
5.000 -0.4% | 29,92 | 149.600 USD | |
2020-04-17 | 2020-04-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-0.4%
29,77148.850 USD |
5.000 -0.4% | 29,77 | 148.850 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
300
-0.0%
23,867.158 USD |
300 -0.0% | 23,86 | 7.158 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
3.212
-0.3%
22,2871.557 USD |
3.212 -0.3% | 22,28 | 71.557 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
15.065
-1.4%
21,58325.088 USD |
15.065 -1.4% | 21,58 | 325.088 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
12.060
-1.1%
20,69249.558 USD |
12.060 -1.1% | 20,69 | 249.558 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
700
-0.1%
22,2915.600 USD |
700 -0.1% | 22,29 | 15.600 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
2.192
-0.2%
21,5747.279 USD |
2.192 -0.2% | 21,57 | 47.279 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
2.108
-0.2%
20,7343.695 USD |
2.108 -0.2% | 20,73 | 43.695 USD | |
2020-02-20 | 2020-02-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-0.5%
40,67203.330 USD |
5.000 -0.5% | 40,67 | 203.330 USD | |
2020-02-20 | 2020-02-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
30.637
-2.9%
40,661.245.792 USD |
30.637 -2.9% | 40,66 | 1.245.792 USD | |
2020-01-17 | 2020-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-0.5%
41,47207.350 USD |
5.000 -0.5% | 41,47 | 207.350 USD | |
2020-01-17 | 2020-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
4.562
-0.5%
42,55194.099 USD |
4.562 -0.5% | 42,55 | 194.099 USD | |
2020-01-17 | 2020-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
26.076
-2.5%
42,161.099.338 USD |
26.076 -2.5% | 42,16 | 1.099.338 USD | |
2019-10-16 | 2019-10-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
3.524
-0.3%
26,6193.784 USD |
3.524 -0.3% | 26,61 | 93.784 USD | |
2019-10-16 | 2019-10-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
1.476
-0.1%
25,5937.766 USD |
1.476 -0.1% | 25,59 | 37.766 USD | |
2019-09-17 | 2019-09-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
260
-0.0%
27,177.064 USD |
260 -0.0% | 27,17 | 7.064 USD | |
2019-09-17 | 2019-09-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
4.740
-0.5%
26,56125.885 USD |
4.740 -0.5% | 26,56 | 125.885 USD |